It’s Tip off Season for the Harlem Globetrotters Tickets Go on Sale Today for the Harlem Globetrotters 2025 World Tour
The World-Famous, Harlem Globetrotters are coming to a city near you! The legendary and awe-inspiring basketball team have announced their upcoming 2025 World Tour beginning Thursday, December 26, 2024 with global tickets on sale today, it was announced by Keith Dawkins, President, Harlem Globetrotters & Herschend Entertainment Studios.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916952134/en/
(L-R) Rock 'Wham' Middleton, Donte 'Hammer' Harrison (Photo: Business Wire)
“The Harlem Globetrotters continue to be celebrated as ambassadors of goodwill, combining sportsmanship and entertainment while bringing joy to families all over the world,” said Dawkins. “Our global tour remains a core part of our business but we’ve also been able to expand the brand with new widely distributed content, new strategic partners, unique merchandise offerings, elevated social extensions and deeper fan experiences. This increased activity has us well positioned for our 100-year anniversary in 2026 and beyond.”
Revered for their exceptional athleticism, basketball wizardry, and heartwarming interactions with fans of all ages, they will captivate audiences with never-before-seen tricks, fan engagement, and heartwarming moments that have become synonymous with the Harlem Globetrotters. Tour schedule and ticket purchase can be found HERE and directly on the Harlem Globetrotters website.
The North American leg of the tour, sponsored by Jersey Mike’s Subs, begins Thursday, December 26 with the tour continuing throughout spring 2025. International markets such as France, United Kingdom, Italy, Germany, Spain, Switzerland, Belgium, Netherlands, Mexico and across Asia are just a few of the many locations the Harlem Globetrotters will be touring in, winter 2025 and running through the remainder of the year. Spalding continues its role as the official global ball partner of the Harlem Globetrotters.
Citi cardmembers will have access to pre-sale tickets in select markets beginning 10:00 a.m. ET Tuesday, September 17th - Sunday, September 29th 10:00 p.m. ET through the Citi Entertainment program. For complete presale details visit www.citientertainment.com
The Harlem Globetrotters Pre-Sale Begins Monday, September 23rd. Fans can request an early access code now at HarlemGlobetrotters.com.
ABOUT THE WORLD-FAMOUS HARLEM GLOBETROTTERS™ / HERSCHEND ENTERTAINMENT STUDIOS
The Harlem Globetrotters™ are THE originators of basketball style; captured by their dynamic athleticism, unique skill and historical influence on the modern game of basketball. Since 1926, the Globetrotters, proud members of the Naismith Memorial Basketball Hall of Fame, have used their legendary global tour to showcase their iconic brand of basketball to tens of millions in over 124 countries and territories across six continents.
They have expanded the brand by coming back to network television for the first time in 40 years with their Emmy nominated NBC series “Harlem Globetrotters: Play it Forward” which also airs onTelemundo as “Harlem Globetrotters: Ganando Con La Comunidad.” Content partners include Hidden Pictures, Atmosphere TV, and Hearts Media Production Group; consumer partnerships include, Sprayground, Undercrwn, Macys, Hybrid; and additional partnerships include our official tour partner Jersey Mikes, official ball partner, Spalding, Viral Nation, Hoopculture, and Citi.
Coined by the U.S. State Department in 1951 as Ambassadors of Goodwill, the team leverages their moniker to drive its Corporate Social Responsibility (CSR) efforts around their strategic pillars of Health & Wellness, Education, and Community Empowerment. These efforts have yielded partnership with the likes of Microsoft, U.S. State Department Sports Diplomacy, The National Archives, ‘Great Assist’ in partnership with Jersey Mike’s Subs, Campus Multimedia Court of Creativity, and Comic Relief Red Nose Day.
For more information about the Harlem Globetrotters™ and the Tour, visit the Globetrotters' official website: www.harlemglobetrotters.com. The Harlem Globetrotters™ is a subsidiary of Herschend, the largest family-owned themed attractions company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916952134/en/
Contacts
Harlem Globetrotters Contact:
Mirian Arias / mirian.arias@harlemglobetrotters.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom